Palatin Technologies, Inc.

AMEX:PTN

Biotechnology

Healthcare
$9.09 -0.82%

-$0.10 today

Market cap
$236.39M
Beta
0.94
P/E (TTM)
-1.9
EPS (TTM)
-$6.43
52W Low $5.00High $31.00

Volume 0.02M

Average 1.78M

PTN Account Payables

Amounts the company owes suppliers for goods and services received.

Palatin Technologies, Inc.AMEX: PTN

Account Payables · Q3 FY2026 · quarter ended Mar 2026

Account payables falls 78.2% from a year ago

Account payables stood at $1.69M at the end of Q3 FY2026, down 78.2% from a year earlier and down 68.9% from the prior quarter. Over 3 fiscal years it compounded at +30.4% a year.

Context

  • Account payables amounted to 12.8% of total assets at the end of Q3 FY2026, down 195.6 pp from a year earlier.
  • Account payables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether account payables keeps falling in the next quarterly balance sheet after a -78.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1.69M-68.9% QoQ
Last fiscal yearJun 2025
$7M+70.6% YoY
Year agoMar 2025
$7.77M-78.2% since
Account Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-78.2%——
1 year+70.6%——
3-year CAGR+30.4%——
5-year CAGR——
10-year CAGR——

Account Payables history

USD · from the balance sheet

Latest · FY2025
7M USD
Year-over-year change
+70.6%
4-year CAGR
+81.8%

Account Payables vs competitors

How PTN compares with its peers on the latest reported figures

  • PTN's Mar 2026 account payables of $1.69M is the highest of the 2 companies compared; the peer median is $653K.
  • Its year-over-year change of -78.2% is the lowest of 2, against a peer median of -75.9%.
  • Account payables amounts to 12.8% of total assets for PTN, versus a peer median of 1.0%.
PTN Competitors Peer median
Account Payables for PTN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PTNPalatin Technologies, Inc.Mar 2026$1.69M -78.2%+30.4%12.8%
QTTBQ32 Bio Inc.Mar 2026$653K -75.9%-15.1%1.0%
Peer median (excluding PTN) $653K-75.9%-15.1%1.0%

Competitors are the stored peer set for PTN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Cash & Equivalents60.1M29.94M7.99M9.53M2.56M
Short-term Investments002.99M00
Net Receivables1.58M1.78M2.92M029.47K
Inventory1.16M944.47K526K00
Other Current Assets2.35M1.12M1.08M147.25K325.7K
Total Current Assets65.91M34.6M16.32M9.77M2.92M
Property, Plant & Equipment (Net)1.33M1.42M1.56M915.68K290.61K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets56.92K56.92K56.92K56.92K56.92K
Total Non-current Assets1.39M1.47M1.62M972.6K347.53K
Total Assets67.3M36.07M17.94M10.74M3.27M
Account Payables640.65K3.16M4.3M4.1M7M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities3.72M7.3M5.42M2.72M881.41K
Total Current Liabilities10.51M16.26M15.13M9.66M8.01M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities6.23M2.86M4.2M1.03M(1)
Total Non-current Liabilities7.13M3.54M4.79M1.2M33.97K
Total Liabilities17.65M19.8M19.92M10.85M8.04M
Common Stock92.02K92.71K116.57K179.27K9.3K
Retained Earnings(351.8M)(387.99M)(412.03M)(441.77M)(459.07M)
Accumulated OCI(0)0000
Other Stockholders Equity00000
Minority Interest00000
Total Equity49.65M16.27M(1.98M)(111.5K)(4.78M)
Total Debt1.25M1.15M1.05M590.34K163.78K
Net Debt(58.85M)(28.79M)(6.94M)(8.94M)(2.4M)

Palatin Technologies, Inc.

AMEX:PTN

Intrinsic Alpha fair value

Locked

Current Price

$9.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.